Infection with the opportunistic fungal pathogen Pneumocystis is assumed to pass without persistent pathology in immunocompetent hosts. However, when immunocompetent BALB/c mice were inoculated with Pneumocystis, a vigorous Th2-like pulmonary inflammation ensued and peaked at 14 days postinfection. This coincided with a 10-fold increase in the number of antigen-presenting cells (APCs) in the lung, and these cells were capable of presenting antigen in vitro, as well as greater uptake of antigen in vivo. When mice were presented with exogenous antigen at the 14-day time point of the infection, they developed respiratory sensitization to that antigen, in the form of increased airway hyperresponsiveness upon a later challenge, whereas mice not infected but presented with antigen did not. Like other forms of collateral sensitization, this response was dependent on interleukin-4 receptor signaling. This ability to facilitate sensitization to exogenous antigen has been previously reported for other infectious disease agents; however, Pneumocystis appears to be uniquely capable in this respect, as a single intranasal dose without added adjuvant, when it was administered at the appropriate time, was sufficient to initiate sensitization. Pneumocystis infection probably occurs in most humans during the first few years of life, and in the vast majority of cases, it fails to cause any overt direct pathology. However, as we show here, Pneumocystis can be an agent of comorbidity at this time by facilitating respiratory sensitization that may relate to the later development or exacerbation of obstructive airway disease.The AIDS epidemic of the 1980s brought to light the previously obscure atypical fungus Pneumocystis as the cause of a serious and often fatal pneumonia in immunocompromised patients (54). Little was known about this organism at the time, but years of focused research have elucidated likely mechanisms of pathology in Pneumocystis pneumonia (reviewed in reference 14). In contrast to this increased knowledge of Pneumocystis in the immunosuppressed host, there is still very little known about the nature of Pneumocystis infection in the immunocompetent host. It is widely assumed that Pneumocystis causes a mild respiratory infection in human infants that results in persistent immunity. This is supported by multiple studies showing that over the first 2 to 3 years of life, greater than 80% of children seroconvert to positivity for Pneumocystis (41,55). Furthermore, the lack of any correlation between clinical illness and a common definitive diagnosis of Pneumocystis infection speaks to the relative mildness and apparent lack of pathology associated with these infections (30). Nonetheless, a recent retrospective study of young children hospitalized for respiratory infections found that 16% tested positive for Pneumocystis, although those testing positive were twice as likely to have an upper respiratory tract infection (URTI) as opposed to a lower respiratory tract infection (LRTI) (32).In spite of the fact that most chi...